The high-risk group encompasses individuals exhibiting multiple APLA positivity, LAC positivity, or persistent anticardiolipin positivity, along with the concomitant presence of autoimmune disease such as systemic lupus erythematosus or rheumatoid arthritis [11]. This evidence concerns the gene LCT and autoimmune disease.